Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.

Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, Bastin KT, Watson G, Burri S, Stea B.

Neurosurgery. 2006 Apr;58(4):701-9; discussion 701-9. Erratum in: Neurosurgery. 2006 Oct;59(4):821.

PMID:
16575334
2.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
3.

GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.

Welsh J, Sanan A, Gabayan AJ, Green SB, Lustig R, Burri S, Kwong E, Stea B.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):159-65. Epub 2007 Feb 27.

PMID:
17331666
4.

Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.

Kleinberg L, Yoon G, Weingart JD, Parisi M, Olivi A, Detorie NA, Chan TA.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1385-91. doi: 10.1016/j.ijrobp.2008.12.074. Epub 2009 Apr 23.

PMID:
19394153
5.

The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.

Wernicke AG, Sherr DL, Schwartz TH, Pannullo SC, Stieg PE, Boockvar JA, Moliterno JA, Ivanidze J, Trichter S, Sabbas AM, Parashar B, Nori D.

Brachytherapy. 2010 Jan-Mar;9(1):91-9. doi: 10.1016/j.brachy.2009.06.005. Epub 2009 Oct 21.

PMID:
19850535
6.

Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy.

Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R, Dowsett R.

Am J Clin Oncol. 2002 Dec;25(6):606-11.

PMID:
12478010
7.

3D conformal radiotherapy and cisplatin for recurrent malignant glioma.

VanderSpek L, Fisher B, Bauman G, Macdonald D.

Can J Neurol Sci. 2008 Mar;35(1):57-64.

PMID:
18380278
8.

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.

Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9.

PMID:
9486616
9.

Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection.

Wernicke AG, Sherr DL, Schwartz TH, Pannullo SC, Stieg PE, Boockvar JA, Ivanidze J, Moliterno JA, Parashar B, Trichter S, Sabbas AM, Nori D.

J Cancer Res Ther. 2010 Jan-Mar;6(1):65-74. doi: 10.4103/0973-1482.63547.

10.

Interstitial brachytherapy procedures for brain tumors.

Sneed PK, McDermott MW, Gutin PH.

Semin Surg Oncol. 1997 May-Jun;13(3):157-66. Review.

PMID:
9143053
11.

Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.

Videtic GM, Gaspar LE, Zamorano L, Fontanesi J, Levin KJ, Kupsky WJ, Tekyi-Mensah S.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):687-92.

PMID:
10524423
12.

Radiotherapy in supratentorial gliomas. A study of 821 cases.

Heesters M, Molenaar W, Go GK.

Strahlenther Onkol. 2003 Sep;179(9):606-14.

PMID:
14628126
13.

Survival and functional status after resection of recurrent glioblastoma multiforme.

Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB.

Neurosurgery. 1998 Apr;42(4):709-20; discussion 720-3.

PMID:
9574634
14.

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

Patel S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew JM Jr.

Neurosurgery. 2000 May;46(5):1123-8; discussion 1128-30.

PMID:
10807244
15.

Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.

Fitzek MM, Thornton AF, Harsh G 4th, Rabinov JD, Munzenrider JE, Lev M, Ancukiewicz M, Bussiere M, Hedley-Whyte ET, Hochberg FH, Pardo FS.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):131-7.

PMID:
11516862
16.

12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.

Schueller P, Micke O, Palkovic S, Schroeder J, Moustakis C, Bruns F, Schuck A, Wassmann H, Willich N.

Strahlenther Onkol. 2005 Aug;181(8):500-6.

PMID:
16044217
17.

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.

Tatter SB, Shaw EG, Rosenblum ML, Karvelis KC, Kleinberg L, Weingart J, Olson JJ, Crocker IR, Brem S, Pearlman JL, Fisher JD, Carson K, Grossman SA; New Approaches to Brain Tumor Therapy Central Nervous System Consortium.

J Neurosurg. 2003 Aug;99(2):297-303.

PMID:
12924704
18.

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M.

Strahlenther Onkol. 2004 Jul;180(7):401-7. Review.

PMID:
15241527
19.

Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.

Gobitti C, Borsatti E, Arcicasa M, Roncadin M, Franchin G, Minatel E, Skrap M, Zanotti B, Tuniz F, Cimitan M, Capra E, Drigo A, Trovò MG.

Tumori. 2011 Sep-Oct;97(5):614-9. doi: 10.1700/989.10721.

PMID:
22158493
20.

Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.

Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):825-30. Epub 2007 May 23.

PMID:
17512132

Supplemental Content

Support Center